Mutual Fund Details
NAV
₹173.0122
as on 15 Sep 2026, 11:15 PM
₹-1.6945(0.97%)
Last Change
Scheme Ratings
2
rated byValue Research
Pharma
Rankings based on | as on Invalid date
×
Download the Paytm Money app now!
Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.
Zero brokerage for 30 days- Zero account opening fees
- Zero AMC for life
Scan QR code to download the app
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,66,604
₹1,71,146
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹71,146
Profit (absolute return)
71.15%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 1 month
0.32%
In the last 3 months
8.47%
In the last 6 months
12.42%
In the last 1 year
12.63%
In the last 3 years
71.15%
In the last 5 years
89.84%
In the last 10 years
335.04%
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
Nippon India Pharma Fund Direct-IDCW Payout
as of 31 Aug 2026, 05:30 AM
₹9,479.08 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 month.
1.00%
Expense Ratio
Plan
Dividend
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 month.
Scheme Document
Sectors Holding in this Mutual Fund
as on31 Aug 2026
Healthcare
97.99%
₹9,288.55 Cr
Others
2.01%
₹190.53 Cr
Companies Holding in this Mutual Fund
as on31 Aug 2026
Sun Pharmaceutical Industries Ltd.
12.37%
₹1,172.56 Cr
Divi's Laboratories Ltd.
7.00%
₹663.54 Cr
Lupin Ltd.
6.43%
₹609.50 Cr
Cipla Ltd.
6.09%
₹577.28 Cr
Apollo Hospitals Enterprise Ltd.
5.15%
₹488.17 Cr
Others
62.96%
₹5,968.03 Cr
View All
View All
Companies Holding in this Mutual Fund
as on31 Aug 2026
Sun Pharmaceutical Industries Ltd.
12.37%
₹1,172.56 Cr
Divi's Laboratories Ltd.
7.00%
₹663.54 Cr
Lupin Ltd.
6.43%
₹609.50 Cr
Cipla Ltd.
6.09%
₹577.28 Cr
Apollo Hospitals Enterprise Ltd.
5.15%
₹488.17 Cr
Others
62.96%
₹5,968.03 Cr
View All
View All
This fund's returns:
19.36%Return Duration
3 Years
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.36%
25.10%
3Y Returns
25.10
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.36%
25.10%
3Y Returns
24.69
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
19.36%
25.10%
3Y Returns
23.42
AboutNippon India Pharma Fund Direct-IDCW Payout
Nippon India Pharma Fund Direct-IDCW Payout is aEquity mutual fund scheme fromNippon India Mutual Fund. This scheme was launched onInvalid date. It has an AUM of ₹9,479.08 Crores and the latest NAV decalared is ₹173.012 as on16 Sep 2026 at1:04 am.
Nippon India Pharma Fund Direct-IDCW Payout scheme return performance in last 1 year is 12.63%, in last 3 years is 71.15% and 821.37% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹9,479.08 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
Nippon India Mutual Fund
View AMC Details
₹7,57,199.84 Cr
AUM
317
Schemes
Address
30th Floor, One Lodha PlaceSenapati Bapat Marg, Lower ParelMumbai400013
Phone Number
Phone :+91 022 6808 7000
Fax :+91 022 6808 7097
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
